Duke Suspends Enrolling New Patients in 3 Clinical Trials

Duke University has suspended the enrollment of new patients in three clinical trials that depend in part on work by a scientist at the university who may have falsely claimed to have been a Rhodes scholar, The News & Observer reported. Duke has placed the scientist, Anil Potti, on administrative leave. (This item has been corrected from an earlier version.)